GetTopicDetailResponse(id=e7ea30e206, topicName=Ayvakit, introduction=Ayvakit, content=null, image=null, comments=1, allHits=599, url=https://h5.medsci.cn/topic?id=3072, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98670, tagList=[TagDto(tagId=98670, tagName=Ayvakit)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780263, encodeId=ae3f1e8026309, content=<a href='/topic/show?id=e7ea30e206' target=_blank style='color:#2F92EE;'>#Ayvakit#</a>, objectTitle=Blueprint的Ayvakit成為美國(guó)獲批治療罕見胃腸道間質(zhì)瘤突變的靶向療法, objectType=article, longId=186045, objectId=eda21860459a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eda21860459a, replyNumber=0, likeNumber=90, createdTime=2020-09-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eda21860459a, moduleTitle=Blueprint的Ayvakit成為美國(guó)獲批治療罕見胃腸道間質(zhì)瘤突變的靶向療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=eda21860459a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
